• user warning: Got error 28 from storage engine query: SELECT t.tid, t.* FROM term_data t INNER JOIN term_hierarchy h ON h.parent = t.tid WHERE h.tid = 18685 ORDER BY weight, name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 755.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27874 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 26211 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

infection

Optimer Pharma Jumps After Stock Grants, Ahead of FDA Advisory Meeting

Published on Fri, 04/01/2011 - 09:25
By FNNO Staff

Each stock option has an exercise price per share equal to $11.83, the fair market value on the grant date, and vests over four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commenceme

advisory committee, board, diarrhea, drug, fda, fidaxomicin, financial, infection, medical, optimer, optr, patient, pharma, shares, stock, treatment

Optimer Pharmaceuticals (OPTR) says that on March 31, its Board approved the grant of inducement stock options to purchase an aggregate of 258,000 shares of common stock to 7 new employees.

By FNNO Staff
fnnonline@gmail.com

Healthcare Sector Update: March 23, 2011

Published on Wed, 03/23/2011 - 15:19
By Stephanie Shyu
clinical trial, disease, gild, gilead, healthcare, hiv, infection, medical, patients, retroviral, science, sector, shares, stock, treatment, viral, virus, xoma

Health care shares are lower in mid-session trading while Xoma (XOMA) tumbles after disappointing results from a clinical trial. The company is down nearly 30% in early trading, after it said late Tuesday its Phase 2b trial of XOM

By Stephanie Shyu
sshyu@fnno.com

Most Popular Video News